Australia - English - Department of Health (Therapeutic Goods Administration)

vital diagnostics pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 28.5 mg (equivalent: nortriptyline, qty 25 mg) - tablet, uncoated - excipient ingredients: maize starch; lactose monohydrate; magnesium stearate - treatment of major depression

Australia - English - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - oxygen, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australia - English - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - oxygen, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - ? hypoxia of any cause. ? as diluent for gaseous and volatile anaesthetic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - dl-alpha-tocopherol, quantity: 0.64 mg/ml; retinol palmitate, quantity: 135.3 microgram/ml; phytomenadione, quantity: 20 microgram/ml; ergocalciferol, quantity: 1 microgram/ml - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections; glycerol; egg lecithin; soya oil - vitalipid n infant is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat- soluble vitamins a, d2, e and k1 in paediatric patients up to 11 years of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - phytomenadione, quantity: 15 microgram/ml; ergocalciferol, quantity: 0.5 microgram/ml; retinol palmitate, quantity: 194.1 microgram/ml; dl-alpha-tocopherol, quantity: 0.91 mg/ml - injection, concentrated - excipient ingredients: soya oil; egg lecithin; glycerol; water for injections; sodium hydroxide - vitalipid n adult is indicated as a supplement in complete intravenous nutrition to meet the daily requirements of the fat- soluble vitamins a, d2, e and k1.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - nortriptyline, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; hypromellose; glycerol; maize starch; calcium phosphate; sunset yellow fcf aluminium lake - allegron is indicated for the treatment of major depression.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - nortriptyline, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; hypromellose; calcium phosphate; maize starch; glycerol; magnesium stearate - allegron is indicated for the treatment of major depression.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - nortriptyline hydrochloride, quantity: 11.4 mg (equivalent: nortriptyline, qty 10 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch - treatment of major depression